Juisci Secures €5.5M Seed for AI HealthTech Expansion

Paris-based Juisci, a leading HealthTech company, has secured €5.5 million in Seed funding. Big Pi Ventures led the round. This investment will boost Juisci's research and development efforts. Furthermore, it supports team scaling and accelerates international expansion, particularly into the U.S. market.

StartupHub data

Companies working on this

Profiles of the companies named in this story, with funding and a one-liner from our database.

Juisci

$6M

Juisci makes scientific publications more accessible, digestible and easier to share within the medical community. Get started now.

Tempus AI

$3.1B

AI-enabled precision medicine platform using clinical and molecular data to improve patient outcomes.

Robin Roumengas and Dr David Luu founded Juisci in 2021. This Juisci HealthTech solution democratizes access to scientific knowledge using proprietary AI and a mobile-first experience.

Juisci aims to save professionals time.

Consequently, it advances medical progress by fighting misinformation.

Advancing Medical Knowledge Access

Juisci's platform transforms vast scientific data into actionable insights. Additionally, it provides digestible summaries, article recommendations, and multimedia content. Over 200,000 users in 60 countries currently leverage Juisci's tools. The Juisci HealthTech platform saves them up to eight hours weekly.

The company works with major pharmaceutical and MedTech firms, including Sanofi and Johnson & Johnson. Furthermore, Juisci addresses the challenge of exploding medical knowledge, which doubles every 73 days. Unlike traditional publishers like Elsevier or data platforms such as Tempus AI, Juisci offers an AI innovation for mobile-first access. This HealthTech startups funding round will fuel its global reach.